New Key Statistics Module, Z-Score and F-Score
NAS:TGTX Key Ratios
Market Cap $ M | 2,154.17 |
Enterprise Value $ M | 2,068.69 |
P/E(ttm) | 1,395.00 |
PE Ratio without NRI | 1,395.00 |
Forward PE Ratio | 140.47 |
Price/Book | 13.16 |
Price/Sales | 9.20 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 233.00 |
EPS (TTM) $ | 0.01 |
Beneish M-Score | 71.93 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 80.57 |
EV-to-EBITDA | 79.26 |
PEG | -- |
Shares Outstanding M | 154.42 |
Net Margin (%) | 5.42 |
Operating Margin % | 8.83 |
Pre-tax Margin (%) | 5.59 |
Quick Ratio | 5.18 |
Current Ratio | 5.92 |
ROA % (ttm) | 4.98 |
ROE % (ttm) | 14.03 |
ROIC % (ttm) | 34.38 |
Dividend Yield % | -- |
Altman Z-Score | 3.16 |
Piotroski F-Score | 5.00 |
Positive ROA | Y |
Positive CFROA | N |
Higher ROA y-y | Y |
Cash flow > Earnings | N |
Lower Leverage y-y | N |
Higher Current Ratio y-y | Y |
Less Shares Outstanding y-y | N |
Gross Margin Increase y-y | Y |
Higher Asset Turnover y-y | Y |
TGTX Number of Guru Trades
TGTX Volume of Guru Trades
Gurus Latest Trades with NAS:TGTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:TGTX is held by these investors
Total 2
TG Therapeutics Inc Insider Transactions
No Available Data
News about NAS:TGTX
Total 0- 1